Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia

Acta Psychiatrica Scandinavica

Volumn 110, Issue 2, 2004, Pages 83-91

  Keri S ^a,b   Janka, Z ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cognitive dysfunction; Endophenotype; Gene; Schizophrenia

Indexed keywords

ATTENTION; AUDITORY STIMULATION; BRAIN FUNCTION; COGNITIVE DEFECT; DISEASE PREDISPOSITION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; REVIEW; SCHIZOPHRENIA; SMOOTH PURSUIT EYE MOVEMENT; VERBAL MEMORY; VISUAL STIMULATION; WORKING MEMORY;

CASE-CONTROL STUDIES; COGNITION DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMORY; MENTAL PROCESSES; OCULAR MOTILITY DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 3242813609     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0047.2004.00359.x     Document Type: Review

References (65)

1. OWEN MJ, O'DONOVAN M, GOTTESMAN II. Psychiatric genetics and genomics. Oxford: Oxford University Press, 2003.
2. PORTIN P, ALANEN YO. A critical review of genetic studies of schizophrenia. I. Epidemiological and brain studies. Acta Psychiatr Scand 1997;95:1-5.
3. GOTTESMAN II, GOULD TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.
4. KEEFE RSE. Working memory dysfunction and its relevance to schizophrenia. In: SHARMA T. HARVEY P, eds. Cognition in schizophrenia. Oxford: Oxford University Press, 2000.
5. PALMER BW, HEATON RK. Executive dysfunction in schizophrenia. In: SHARMA T, HARVEY P, eds. Cognition in Schizophrenia. Oxford: Oxford University Press, 2000.
6. CHEN WJ, FARAONE SV. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet 2000;97:52-57.
7. SCHWARTZ BD, TOMLIN HR, EVANS WJ, ROSS KV. Neurophysiologic mechanisms of attention: a selective review of early information processing in schizophrenics. Front Biosci 2001;6:D120-134.
8. CIRILLO MA, SEIDMAN LJ. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 2003;13:43-77.
9. HOLZMAN PS. Less is truly more: psychopathology research in the 21st century. In: LENZENWEGER MF, HOOLEY J, eds. Principles of psychopathology: essays in honor of Brendan A. Maher. Washington, DC: American Psychological Association, 2003.
10. WEICKERT TW, GOLDBERG TE. The course of cognitive impairment in patients with schizophrenia. In: SHARMA T, HARVEY P, eds. Cognition in schizophrenia. Oxford: Oxford University Press, 2000.
11. EGAN MF, GOLDBERG TE, KOLACHANA BS et al. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001;98:6917-6922.
12. GOLDSTEIN G, SHEMANSKY WJ. Influences on cognitive heterogeneity in schizophrenia. Schizophr Res 1995;18:59-69.
13. PALMER BW, HEATON RK, PAULSEN JS et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997;11:437-446.
14. WEICKERT TW, GOLDBERG TE, GOLD JM, BIGELOW LB, EGAN MF, WEINBERGER DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 2000;57:907-913.
15. EGAN MF, GOLDBERG TE, GSCHEIDLE T et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry 2001;50:98-107.
16. TURETSKY BI, MOBERG PJ, MOZLEY LH et al. Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology 2002;16:481-490.
17. KÉRI S, SZENDI I, KELEMEN O, BENEDEK G, JANKA Z. Remitted schizophrenia-spectrum patients with spared working memory show information processing abnormalities. Eur Arch Psychiatry Clin Neurosci 2001;251:60-65.
18. KREMEN WS, SEIDMAN LJ, FARAONE SV, TOOMEY R, TSUANG MT. The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol 2000;109:743-752.
19. KÉRI S, KELEMEN O, BENEDEK G, JANKA Z. Verbal description of visual categories in patients with schizophreniform disorder. Psychol Med 2004;34:247-253.
20. NIEMI LT, SUVISAARI JM, TUULIO-HENRIKSSON A, LONNQVIST JK. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res 2003;60:239-258.
21. GSCHWANDTNER U, ASTON J, BORGWARDT S et al. Neuropsychological and neurophysiological findings in individuals suspected to be at risk for schizophrenia: preliminary results from the Basel Early Detection of Psychosis Study - Fruherkennung von Psychosen (FEPSY). Acta Psychiatr Scand 2003;108:152-155.
22. CANNON TD, ZORILLA LE, SHTASEL D et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry 1994;51:651-661.
23. KREMEN WS, SEIDMAN LJ, PEPPLE JR, LYONS MJ, TSUANG MT, FARANOE SV. Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 1994;20:103-119.
24. EGAN MF, GOLDBERG TE, GSCHEIDLE T, WEIRICH M, BIGELOW LB, WEINBERGER DR. Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry 2000;157:1309-1316.
25. CORNBLATT BA, KEILP JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizopr Bull 1994;20:31-46.
26. COSWAY R, BYRNE M, CLAFFERTY BA et al. Sustained attention in young people at risk for schizophrenia. Psychol Med 2002;30:1111-1121.
27. BYRNE M, CLAFFERTY BA, COSWAY R et al. Neuropsychology, genetic liability, and psychotic symptoms in those at high risk of schizophrenia. J Abnorm Psychol 2003;112:38-48.
28. FARANOE SV, SEIDMAN LJ, KREMEN WS et al. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol 1995;104:286-304.
29. FARANOE SV, SEIDMAN LJ, KREMEN WS et al. Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry 2000;48:120-126.
30. KÉRI S, KELEMEN O, BENEDEK G, JANKA Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 2001;31:915-922.
31. GREEN MF, NUECHTERLEIN KH. Backward masking as an indicator of vulnerability to schizophrenia. Acta Psychiatr Scand 1999;99(suppl. 395):34-40.
32. GASPERONI TL, EKELUND J, HUTTUNEN M et al. Genetic linkage and association between chromosome 1q and working memory function in schizophrenia. Am J Med Genet 2003;116:8-16.
33. TOULOPOULOU T, MORRIS RG, RABE-HESKETH S, MURRAY RM. Selectivity of verbal memory deficit in schizophrenic patients and their relatives. Am J Med Genet 2003;116:1-7.
34. ADLER LE, FREEDMAN R, ROSS RG, OLINCY A, WALDO MC. Elementary phenotypes in the neurobiological and genetic study of schizophrenia. Biol Psychiatry 1999;46:8-18.
35. GOUROVITCH ML, TORREY EF, GOLD JM, RANDOLPH C, WEINBERGER DR, GOLDBERG TE. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 1999;45:639-646.
36. KATHMANN N, HOCHREIN A, UWER R, BONDY B. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry 2003;160:696-702.
37. AROLT V, LENCER R, PURMANN S et al. Testing for linkage of eye tracking dysfunction and schizophrenia to markers on chromosomes 6, 8, 9, 20, and 22 in families multiply affected with schizophrenia. Am J Med Genet 1999;88:603-606.
38. GOLDBERG TE, EGAN MF, GSCHEIDLE T et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003;60:889-896.
39. BILDER RM, VOLAVKA J, CZOBOR P et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002;52:701-707.
40. TSAI SJ, YU YW, CHEN TJ et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003;338:123-126.
41. ROXBOROUGH H, MUIR WJ, BLACKWOOD DH, WALKER MT, BLACKBURN IM. Neuropsychological and P300 abnormalities in schizophrenics and their relatives. Psychol Med 1993;23:305-314.
42. GALLINAT J, BAJBOUJ M, SANDER T et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003;54:40-48.
43. ANTAL A, KÉRI S, BODIS-WOLLNER I. Dopamine D2 receptor blockade alters the primary and cognitive components of visual evoked potentials in the monkey, Macaca fascicularis. Neurosci Lett 1997;232:179-181.
44. WINTERER G, EGAN MF, RADLER T, COPPOLA R, WEINBERGER DR. Event-related potentials and genetic risk for schizophrenia. Biol Psychiatry 2001;50:407-417.
45. SZEKERES G, KÉRI S, JUHÁSZ A et al. The role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet 2004;124B:1-5.
46. RYBAKOWSKI JK, BORKOWSKA A, CZERSKI PM, HAUSER J. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Mol Psychiatry 2001;6:718-724.
47. RYBAKOWSKI JK, BORKOWSKA A, CZERSKI PM, HAUSER J. Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene. Psychiatry Res 2002;113:49-57.
48. CALLICOTT JH, EGAN MF, MATTAY VS et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 2003;160:709-719.
49. HECKERS S, RAUCH SL, GOFF D et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1998;1:318-323.
50. BRAUS DF, WEBER-FAHR W, TOST H, RUF M, HENN FA. Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry 2002;59:696-701.
51. O'DRISCOLL GA, BENKELFAT C, FLORENCIO PS et al. Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic patients: a positron emission tomography study. Arch Gen Psychiatry 1999;56:1127-1134.
52. BERMAN KF, OSTREM JL, RANDOLPH C et al. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 1995;33:1027-1046.
53. NUECHTERLEIN KH, BUCHSBAUM MS, DAWSON ME. Neuropsychological vulnerability to schizophrenia. In: DAVID AS, CUTTING JC, eds. The neuropsychology of schizophrenia. Hove: Psychology Press, 1994.
54. ROSENFARB IS, NUECHTERLEIN KH, GOLDSTEIN MJ, SUBOTNIK KL. Neurocognitive vulnerability, interpersonal criticism, and the emergence of unusual thinking by schizophrenic patients during family transactions. Arch Gen Psychiatry 2000;57:1174-1179.
55. MACDONALD AW, POGUE-GEILE MF, JOHNSON MK, CARTER CS. A specific deficit in context processing in the unaffected siblings of patients with schizophrenia. Arch Gen Psychiatry 2003;60:57-65.
56. SPENCE SA, HIRSCH SR, BROOKS DJ, GRASBY PM. Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia. Br J Psychiatry 1998;172:316-323.
57. ELVEVAG B, WEINBERGER DR, SUTER JC, GOLDBERG TE. Continuous performance test and schizophrenia: a test of stimulus-response compatibility, working memory, response readiness, or none of the above? Am J Psychiatry 2000;157:772-780.
58. PARK S, HOOKER C. Increased repetition blindness in schizophrenia patients and first-degree relatives of schizophrenia patients. Schizophr Res 1998;32:59-62.
59. CHEN Y, NAKAYAMA K, LEVY DL, MATTHYSSE S, HOLZMAN PS. Psychophysical isolation of a motion-processing deficit in schizophrenics and their relatives and its association with impaired smooth pursuit. Proc Natl Acad Sci USA 1999;96:4724-4729.
60. KÉRI S, KELEMEN O, BENEDEK G, JANKA Z. Vernier threshold in patients with schizophrenia and their unaffected siblings. Neuropsychology (in press).
61. SELEMON LD. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr Bull 2001;27:349-377.
62. BUTLER PD, LIM KO, NIERENBERG J et al. Primary visual dysfunctions in schizophrenia: relationship to white matter integrity inferred from diffusion tensor imaging. Schizophr Res 2003;60(Suppl. 1):190-191.
63. JANSSEN I, KRABBENDAM L, JOLLES J, VAN OS J. Alterations in theory of mind in patients with schizophrenia and non-psychotic relatives. Acta Psychiatr Scand 2003;108:110-117.
64. LOUGHLAND CM, WILLIAMS LM, HARRIS AW. Visual scanpath dysfunction in first-degree relatives of schizophrenia probands: evidence for a vulnerability marker? Schizophr Res 2004;67:11-21.
65. MUNRO JC, RUSSELL AJ, MURRAY RM, KERWIN RW, JONES PB. IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up. Acta Psychiatr Scand 2002;106:139-142.